Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma - Wikidata - wikimedia - TriplyDB

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

http://www.wikidata.org/entity/Q27860910

about

Improving the extent of malignant glioma resection by dual intraoperative visualization approach Immunosignaturing can detect products from molecular markers in brain cancer Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer Mutational profiling of kinases in glioblastoma.Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma Systemic therapy of Cushing's syndrome External beam radiation dose escalation for high grade glioma Procarbazine, lomustine and vincristine for recurrent high-grade glioma Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Temozolomide for high grade glioma Image guided surgery for the resection of brain tumours Intra-arterial chemotherapy for high-grade gliomas Pharmacological treatment of depression in patients with a primary brain tumour Chemotherapy wafers for high grade glioma Pharmacological treatment of depression in patients with a primary brain tumour Temozolomide for High Grade Glioma Chemotherapeutic wafers for High Grade Glioma Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex Inhibition of Nodal suppresses angiogenesis and growth of human gliomas Targeting energy metabolism in brain cancer: review and hypothesis Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis Ion channels in glioblastoma O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2 MiRNA expression patterns predict survival in glioblastoma Neural stem cells: brain building blocks and beyond Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

P2860

Q21090866-B32B274E-99D3-4D90-9543-5EC9A80EDEBA Q21134151-36ED2759-DD11-4550-9F50-54DE5E15F3D8 Q21135142-94A31435-18A5-47C4-82AE-4E160B22A9C8 Q21144984-4F045D9C-740A-4E57-B741-27769C9D997A Q21203116-4C4CFA38-49C5-4EBC-84C1-CA0F223F7505 Q21261249-3D6D9A42-FEAD-44AF-94E1-36A85F578397 Q21261312-ABDE6818-7E39-4FFF-8B2E-587F93138B00 Q21261321-E6AFEC96-EA85-4F0F-AACA-9783480306A9 Q21560786-BB526AA8-89B2-48FA-ABF8-A8CC14F05CDB Q22000607-3A350C08-CBF2-41DF-8AB5-B83C6C832C05 Q24186922-00062F00-5E99-46F2-B202-747B114FA246 Q24187436-73E77AC5-C6CE-4C4F-8ECC-33CBC90343DE Q24194645-5933AD05-8C42-4B52-9481-33E95B039B18 Q24197645-839F5FA6-CAF0-4670-8E0E-7F9B182E1B73 Q24200959-CEBE3F2F-82A0-4ADC-8F01-C26FCD5EB244 Q24202500-47801341-27FC-49AB-A96D-396615FCAF2A Q24202721-946A3787-6368-46D9-AAB4-963D911425B7 Q24235641-481122E6-E448-4183-8A18-41D089782B78 Q24236728-B83F4C13-A7D6-4EC9-9ADA-14D35E71A3DB Q24241222-6FBF6FD6-3F70-4202-A148-B303A4D9C629 Q24242222-EDB30917-9DB6-4666-B739-89C3BEBEBECA Q24242968-9E4640E8-A237-448D-99E6-BBAA16C4E196 Q24293124-0A23382C-92D0-48BC-ADED-BFBFB0A2BF74 Q24299700-B159E8CC-A409-4300-AC2D-D4F39D27A8A3 Q24306474-33BAB7D5-C5C0-422A-878B-F28837BB094E Q24309876-1EB9B396-8450-4557-8ADA-411658F003DE Q24537119-EAB061EF-56C1-46BF-BD5F-CE40867FDFF8 Q24546291-392C4E7A-94B2-4B34-91EF-17167391A781 Q24603505-CD950DA8-45EF-4A83-A92A-0124A1DDD643 Q24604354-53C2D049-7603-46B2-8C9A-70BD785783E8 Q24604724-3FA1D9A5-54EE-4F62-BC59-DBACB917C2D6 Q24607903-FFC76D42-52F5-4AB5-B1CC-ADE2C320AB23 Q24610377-0BFD4D2E-4F17-4482-B512-24B48259CEF2 Q24614672-138BF343-9198-4CBD-AC4A-FC0A351A8B13 Q24615166-EAA8054F-A555-46BB-A42A-7249C08DD500 Q24628726-67055619-DB7B-4FBE-B467-887FEA40EC74 Q24628857-4CA43211-5D68-42F3-A482-F2C6E4EC9825 Q24629525-FB8B0F46-7243-4CDC-8F46-5924730EB00B Q24631889-ED36CD1A-9390-4161-BD88-DA3AAA371BD8 Q24632791-3F088D77-195B-4987-BC5F-B84073E8DA79

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

http://www.wikidata.org/entity/Q27860910

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@ast

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@en

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@nl

type

label

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@ast

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@en

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@nl

prefLabel

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@ast

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@en

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@nl

P1433

Q27860910-4F6624B4-493B-483C-8E28-B00E4F150047

P1476

Q27860910-EE3423C1-26EC-4E36-9371-93F5994DA8DA

P2093

Q27860910-07145A5D-D8A0-44B1-925E-04F7B7B6D373

Q27860910-0FCE6EE6-C03F-4E18-A44F-E9C077BABBC3

Q27860910-23A6E125-46D1-4CCD-B060-74CAD594C9C2

Q27860910-47520F35-1DF6-447F-AB27-E41A6AB7BCF4

Q27860910-4E3C734C-ADDD-48CD-AA56-56E7FF577861

Q27860910-5D9F9A68-FD74-4C1E-BD0E-14F9549C3F8D

Q27860910-5FF0E8C4-3535-4CBF-B230-4F0580ADB416

Q27860910-6B497C74-6058-46DC-B7CA-9EB40AE5A19E

Q27860910-74BEBA47-5370-4B8F-8C88-60B374067732

Q27860910-786C865C-209C-4CA2-BC25-569B2CEDD68B

P304

Q27860910-FD1CAC8F-1063-4ADA-A281-F4D3952201D6

P31

Q27860910-CF68EAE8-FB01-41F5-A755-237365267A1E

P3181

Q27860910-21107013-146B-4419-B9D1-8D8E95E62391

P356

Q27860910-051BC876-1735-44F7-AEAE-4F5D307C217C

P407

Q27860910-40680B7D-2FEC-4EED-8779-EEB1BC695869

P433

Q27860910-69EC09CB-B874-42AB-B7FA-5605BD6C0B23

P478

Q27860910-CE5FAFB8-B115-4D40-B986-2DE744735135

P50

Q27860910-13ECBA7C-22C2-4D9A-9783-13624312B4FA

Q27860910-20A09482-1EDC-442E-87E6-DB9C9B7D3E30

Q27860910-78E15E7D-7ED2-4B3E-9CCF-EB2A2DE6B757

P577

Q27860910-C0785F19-FAB6-4BE5-B802-53126B4A09F2

P698

Q27860910-C7BF70E9-BA83-40EA-9462-C178145F439E

P921

Q27860910-D2BCF95C-FA59-4613-B1AF-FE5C65F48038

Q27860910-e9b88d37-4e20-e5df-9098-2005e5f7e891

Q27860910-f7644700-4e0e-3a1b-5065-39c903e66b2a

P3181

P356

P1433

The New England Journal of Medicine

P1476

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

@en

P2093

Anouk Allgeier

http://www.w3.org/2001/XMLSchema#string

Barbara Fisher

http://www.w3.org/2001/XMLSchema#string

Christine Marosi

http://www.w3.org/2001/XMLSchema#string

Denis Lacombe

http://www.w3.org/2001/XMLSchema#string

Elizabeth Eisenhauer

http://www.w3.org/2001/XMLSchema#string

J Gregory Cairncross

http://www.w3.org/2001/XMLSchema#string

Jürgen Curschmann

http://www.w3.org/2001/XMLSchema#string

Karl Belanger

http://www.w3.org/2001/XMLSchema#string

Martin J B Taphoorn

http://www.w3.org/2001/XMLSchema#string

Martin J van den Bent

http://www.w3.org/2001/XMLSchema#string

P304

987-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

220559

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA043330

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Alba A. Brandes

P577

2005-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15758009

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy